Jul.07
11:11 AM ET
Monday, 7 Jul 2008
Shares of Merck, which have lost more than a third of their value so far this year, are under continued pressure this morning. They were at 60 bucks in early January. Today they're trading around $37. Big pharma analyst Rupesh Patel at UBS is downgrading the Dow component from Buy to Neutral because he thinks it's gonna be "range-bound near-term"... Read More
Topics:Stock Market | Medicine | Mergers & Acquisitions | Pharmaceuticals
Companies:GlaxoSmithKline plc | IMS Health Inc | Schering Plough Corp | Merck & Co Inc
VIDEO | COMPANIES : IMS Health Inc
Going into 2009 investors should maintain a defensive bias in their portfolio, Philip Lawlor from Nomura told CNBC Thurs...
Opportunities in developing Asia, with Milton Stern, Bridgewater Advisors Inc. founding partner
Helping you get covered by health insurance, with Sandy Praeger, president of The National Associate of Insurance Commis...
More clues about the health of housing and the impact on the markets, with CNBC's Diana Olick, Bob Pisani & Michelle Car...
Discussing investing overseas and keeping your money home, with Art Nunes, IMS Capital Management and Russell Lundeberg,...
More VideosNews |
COMPANY : IMS Health Inc
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes